Expression patterns of the organic cation/carnitine transporter family in adult murine brain

Brain and Development

Volumn 30, Issue 1, 2008, Pages 31-42

  Lamhonwah, Anne Marie ^a,b   Hawkins, Cynthia E ^a   Tam, Carolyn ^a,b   Wong, Jeannie ^a,b   Mai, Lydia ^a,b   Tein, Ingrid ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adult murine brain; Immunohistochemistry; Octn1; Octn2; Octn3; Organic cation carnitine transporters

Indexed keywords

ANTIBODY; HEMATOXYLIN; MOLECULAR LAYER; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HORN CELL; ARCUATE NUCLEUS; ARTICLE; BRAIN; CEREBELLUM; CHOROID PLEXUS; CONTROLLED STUDY; CRANIAL NERVE; DENDRITE; DENDRITIC CELL; DENTATE GYRUS; FACIAL NERVE; HIPPOCAMPUS; MALE; MOTOR CORTEX; MOUSE; NERVE FIBER; NERVE FUNCTION; NONHUMAN; OLFACTORY BULB; OLFACTORY NERVE; PROTEIN EXPRESSION; PURKINJE CELL; SPINAL CORD; TRIGEMINAL NERVE;

ACETYLCHOLINE; AGE FACTORS; ANIMALS; BRAIN; BRAIN DISEASES, METABOLIC; BRAIN MAPPING; CARNITINE; CARRIER PROTEINS; CATIONS; ENERGY METABOLISM; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; NEURAL PATHWAYS; NEURONS; ORGANIC CATION TRANSPORT PROTEINS; SPINAL CORD;

EID: 37349065551     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2007.05.005     Document Type: Article

References (66)

1. Bremer J. Carnitine-metabolism and functions. Physiol Rev 63 (1983) 1420-1480
2. Wu X., Prasad P.D., Leibach F.H., and Ganapathy V. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246 (1998) 589-595
3. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273 (1998) 20378-20382
4. Lamhonwah A.M., and Tein I. Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transporter gene. Biochem Biophys Res Commun 252 (1998) 396-401
5. Nezu J., Tamai I., Oku A., Ohashi R., Yabuuchi H., Hashimoto N., et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21 (1999) 91-94
6. Tang N.L., Ganapathy V., Wu X., Hui J., Seth P., Yuen P.M., et al. Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum Mol Genet 8 (1999) 655-660
7. Lamhonwah A.M., Olpin S.E., Pollitt R.J., Vianey-Saban C., Divry P., Guffon N., et al. Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy. Am J Med Genet 111 (2002) 271-284
8. Tein I., De Vivo D.C., Bierman F., Pulver P., De Meirleir L.J., Cvitanovic-Sojat L., et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 28 (1990) 247-255
9. Stanley C.A., DeLeeuw S., Coates P.M., Vianey-Liaud C., Divry P., Bonnefont J.P., et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 30 (1991) 709-716
10. Bahl J., Navin T., Manian A., and Bressler R. Carnitine transport in isolated adult rat heart myocytes and the effect of 7,8,-diOH chlorpromazine. Circ Res 48 (1981) 378-385
11. Rebouche C.J., and Engel A.G. Carnitine transport in cultured muscle cells and skin fibroblasts from patients with primary systemic carnitine deficiency. In Vitro 18 (1982) 495-500
12. Treem W.R., Stanley C.A., Finegold D.N., Hale D.E., and Coates P.N. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts. N Engl J Med 319 (1988) 1331-1336
13. Pons R., Carrozzo R., Tein I., Walker W.F., Addonizio L.J., Rhead W., et al. Deficient muscle carnitine transport in primary carnitine deficiency. Pediatr Res 42 (1997) 583-587
14. Tamai I., Ohashi R., Nezu J.I., Sai Y., Kobayashi D., Oku A., et al. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275 (2000) 40064-40072
15. Pritchard J.B., and Miller D.S. Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 73 (1983) 765-796
16. Ullrich K.J. Specificity of transporters for 'organic anions' and 'organic cations' in the kidney. Biochim Biophys Acta 1197 (1994) 45-62
17. Zevin S., Schaner M.E., Illsley N.P., and Giacomini K.M. Guanidine transport in a human choriocarcinoma cell line (JAR). Pharm Res 14 (1997) 401-405
18. Tamai I., Yabuuchi H., Nezu J., Sai Y., Oku A., Shimane M., et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419 (1997) 107-111
19. Yabuuchi H., Tamai I., Nezu J., Sakamoto K., Oku A., Shimane M., et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharm Exp Ther 289 (1999) 768-773
20. Wu X., Huang W., Prasad P.D., Seth P., Rajan D., Leibach F.H., et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharm Exp Ther 290 (1999) 1482-1492
21. Ohashi R., Tamai I., Yabuuchi H., Nezu J.I., Oku A., Sai Y., et al. Na (+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291 (1999) 778-784
22. Lamhonwah A.M., Skaug J., Scherer S.W., and Tein I. A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5). Biochem Biophys Res Commun 301 (2003) 98-101
23. Lamhonwah A.M., Ackerley C.A., Tilups A., Edwards V.D., Wanders R.J., and Tein I. OCTN3 is a mammalian peroxisomal membrane carnitine transporter. Biochem Biophys Res Commun 338 (2005) 1966-1972 [Epub 2005 Nov 10]
24. Lamhonwah A.M., and Tein I. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun 345 (2006) 1315-1325 [Epub 2006 May 12]
25. Ramsay R.R. The carnitine acyltransferases: modulators of acyl-CoA-dependent reactions. Biochem Soc Trans 28 (2000) 182-186
26. Zanelli S.A., Solenski N.J., Rosenthal R.E., and Fiskum G. Mechanisms of ischemic neuroprotection by acetyl-l-carnitine. Ann N Y Acad Sci 1053 (2005) 153-161 [Review]
27. Juliet P.A., Balasubramaniam D., Balasubramaniam N., and Panneerselvam C. Carnitine: a neuromodulator in aged rats. J Gerontol A Biol Sci Med Sci 58 (2003) 970-974
28. Binienda Z.K. Neuroprotective effects of L-carnitine in induced mitochondrial dysfunction. Ann N Y Acad Sci 993 (2003) 289-295 [discussion 345-349]
29. Yasui F., Matsugo S., Ishibashi M., Kajita T., Ezashi Y., Oomura Y., et al. Effects of chronic acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice. Neurosci Lett 334 (2002) 177-180
30. Ori C., Freo U., Pizzolato G., and Dam M. Effects of acetyl-L-carnitine on regional cerebral glucose metabolism in awake rats. Brain Res 951 (2002) 330-335
31. Virmani A., Gaetani F., Imam S., Binienda Z., and Ali S. Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity. Ann N Y Acad Sci 993 (2003) 197-207 [discussion 287-288. Review]
32. Picconi B., Barone I., Pisani A., Nicolai R., Benatti P., Bernardi G., et al. Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine. Neuropharmacology 50 (2006) 917-923 [Epub 2006 Feb 24]
33. Wawrzenczyk A., Nalecz K.A., and Nalecz M.J. Effect of gamma-aminobutyric acid on the carnitine metabolism in neural cells. Biochem Biophys Res Commun 213 (1995) 383-388
34. Virmani M.A., Conti R., Spadoni A., Rossi S., and Arrigoni-Martelli E. Inhibition of L-carnitine uptake into primary rat cortical cell cultures by GABA and GABA uptake blockers. Pharmacol Res 31 (1995) 211-215
35. Halpern M., and Martinez-Marcos A. Structure and function of the vomeronasal system: an update. Prog Neurobiol 70 (2003) 245-318
36. Kawano H., and Daikoku S. Somatostatin-containing neuron systems in the hypothalamus: retrograde tracing and immunohistochemical studies. J Comp Neurol 271 (1988) 293-299
37. Price N., van der Leij F., Jackson V., Corstorphine C., Thomson R., Sorensen A., et al. A novel brain-expressed protein related to carnitine palmitoyltransferase I. Genomics 80 (2002) 433-442
38. Wolfgang M.J., Kurama T., Dai Y., Suwa A., Asaumi M., Matsumoto S., et al. The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc Natl Acad Sci USA 103 (2006) 7282-7287 [Epub 2006 May 1]
39. Arduini A., Tyurin V., Tyuruna Y., Arrigoni-Martelli E., Molajoni F., Dottori S., and Federici G. Acyl-trafficking in membrane phospholipid fatty acid turnover: the transfer of fatty acid from the acyl-L-carnitine pool to membrane phospholipids in intact human erythrocytes. Biochem Biophys Res Commun 187 (1992) 353-358
40. Harrold J.A., Widdowson P.S., and Williams G. Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding. Diabetes 48 (1999) 267-271
41. Cai X.J., Widdowson P.S., Harrold J., Wilson S., Buckingham R.E., Arch J.R., Tadayyon M., et al. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 48 (1999) 2132-2137
42. Lowell B.B., and Spiegelman B.M. Towards a molecular understanding of adaptive thermogenesis. Nature 404 (2000) 652-660 [Review]
43. Spiegelman B.M., and Flier J.S. Obesity and the regulation of energy balance. Cell 104 (2001) 531-543 [Review]
44. Ito M. Cerebellum and neural control (1984), Raven Press, New York
45. Kandel E.R., Schwartz J.H., and Jessell T.M. Principles of neural science. 4th ed. (2000), McGraw-Hill, New York
46. Kido Y., Tamai I., Ohnari A., Sai Y., Kagami T., Nezu J., et al. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J Neurochem 79 (2001) 959-969
47. Sterri S.H., and Fonnum F. Acetyl-CoA synthesizing enzymes in cholinergic nerve terminals. J Neurochem 35 (1980) 249-254
48. Castorina M., and Ferraris L. Acetyl-L-carnitine affects aged brain receptorial system in rodents. Life Sci 54 (1994) 1205-1214 [Review]
49. Kentroti S., Ramacci M.T., and Vernadakis A. Acetyl-L-carnitine has a neuromodulatory influence on neuronal phenotypes during early embryogenesis in the chick embryo. Brain Res Dev Brain Res 70 (1992) 259-266
50. Tempesta E., Janiri L., and Pirrongelli C. Stereospecific effects of acetylcarnitine on the spontaneous activity of brainstem neurones and their responses to acetylcholine and serotonin. Neuropharmacology 24 (1985) 43-50
51. Janiri L., Falcone M., Persico A., and Tempesta E. Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo. J Neural Transm Gen Sec 86 (1991) 135-146
52. Abdul H.M., Calabrese V., Calvani M., and Butterfield D.A. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J Neurosci Res 84 (2006) 398-408
53. Traina G., Bernardi R., Rizzo M., Calvani M., Durante M., and Brunelli M. Acetyl-L-carnitine up-regulates expression of voltage-dependent anion channel in the rat brain. Neurochem Int 48 (2006) 673-678 [Epub 2006 Mar 9]
54. Marini G., Calvani M., Ceccarelli P., and Mancia M. Behavioral and electrophysiological changes induced by acetyl-L-carnitine in aged freely-moving rats. Arch Ital Biol 144 (2006) 33-43
55. Adriani W., Rea M., Baviera M., Invernizzi W., Carli M., Ghirardi O., et al. Acetyl-L-carnitine reduces impulsive behaviour in adolescent rats. Psychopharmacology (Berl) 176 (2004) 296-304 [Epub 2004 May 8]
56. Svoboda Z., Kvetina J., Herink J., Bajgar J., Bartosova L., Palicka V., et al. Galantamine antiacetylcholinesterase activity in rat brain influenced by L-carnitine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149 (2005) 335-337
57. Wainwright M.S., Kohli R., Whitington P.F., and Chace D.H. Carnitine treatment inhibits increases in cerebral carnitine esters and glutamate detected by mass spectrometry after hypoxia-ischemia in newborn rats. Stroke 37 (2006) 524-530 [Epub 2005 Dec 29]
58. Tastekin A., Gepdiremen A., Ors R., Emin Buyukokuroglu M., and Halici Z. L-carnitine protects against glutamate- and kainic acid-induced neurotoxicity in cerebellar granular cell culture of rats. Brain Dev 27 (2005) 570-573
59. Hino K., Nishikawa M., Sato E., and Inoue M. l-Carnitine inhibits hypoglycemia-induced brain damage in the rat. Brain Res 1053 (2005) 77-87
60. Haripriya D., Sangeetha P., Kanchana A., Balu M., and Panneerselvam C. Modulation of age-associated oxidative DNA damage in rat brain cerebral cortex, striatum and hippocampus by L-carnitine. Exp Gerontol 40 (2005) 129-135 [Epub 2004 Nov 11]
61. Ramsay R.R., and Zammit V.A. Carnitine acyltransferases and their influence on CoA pools in health and disease. Mol Aspects Med 25 (2004) 475-493
62. Nalecz K.A., Miecz D., Berezowski V., and Cecchelli R. Carnitine: transport and physiological functions in the brain. Mol Aspects Med 25 (2004) 551-567
63. Cederbaum S.D., Koo-McCoy S., Tein I., Hsu B.Y., Ganguly A., Vilain E., et al. Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency. Mol Genet Metab 77 (2002) 195-201 [Erratum in: Mol Genet Metab 2003;78:82]
64. Makhseed N., Vallance H.D., Potter M., Waters P.J., Wong L.T., Lillquist Y., et al. Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy. J Inherit Metab Dis 27 (2004) 778-780
65. Rubio-Gozalbo M.E., Bakker J.A., Waterham H.R., and Wanders R.J. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects. Mol Aspects Med 25 (2004) 521-532
66. Powers J.M., and Moser H.W. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 8 (1998) 101-120